3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: Biological and clinical features

Haematologica

Volumn 84, Issue 8, 1999, Pages 690-694

  Testoni, Nicoletta ^c   Borsaru, Gabriela ^a   Martinelli, Giovanni ^d   Carboni, Cristina ^d   Ruggeri, Deborah ^d   Ottaviani, Emanuela ^d   Pelliconi, Susanna ^d   Ricci, Paolo ^d   Pastano, Rocco ^d   Visani, Giuseppe ^d   Zaccaria, Alfonso ^b   Tura, Sante ^d  

^a Department of Haematology   (Romania)

^b Hematology Department   (Italy)

^c Institute of Hematology and Clinical Oncology 'LA Seragnoli'   (Italy)

^d NONE

Author keywords

3q abnormalities; Acute myeloblastic leukemia; Cytogenetics; EVI 1 expression; Myelodysplastic syndrome

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLUDARABINE; IDARUBICIN; MITOXANTRONE; VALSPODAR;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CHROMOSOME 3Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOGENETICS; DISEASE CLASSIFICATION; FEMALE; GENE EXPRESSION; HUMAN; MALE; MEGAKARYOPOIESIS; SURVIVAL RATE;

ADULT; CELL DIFFERENTIATION; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MEGAKARYOCYTES; MIDDLE AGED;

EID: 0032833342     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bitter MA, Neilly ME, Le Beau MM, Pearson MG, Rowley JD. Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia. Blood 1985, 66:1362-70.
2. Pintado T, Ferro MT, San Roman C, Mayayo M, Larana JG. Clinical correlations of the 3q21;q26 cytogenetic anomaly. Cancer 1985, 55:535-41.
3. Jenkins RB, Terreri A, Solberg LA, Dewald GW. Acute leukemia with abnormal thrombopoiesis and inversions of chromosome 3. Cancer Genet Cytogenet 1989; 39: 167-79.
4. Jotter and Bellomo J, Parlier V, Muhlematter D, Grob JP, Beris P. Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndrome. Cancer Genet Cytogenet 1992; 59:138-60.
5. Grigg AP, Gascoyne RD, Phillips GL, Horsman DE. Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the q arms of chromosome 3. Br J Haematol 1993; 83:158-65.
6. Fonatsch C, Gudat H, Lengfelder E, et al. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26). Leukemia 1994; 8:1318-26.
7. Secker-Walker LM, Mehta A, Bain B, et al. Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study. Br J Haematol 1995; 91:490-501.
8. Shi G, Weh H-J, Duhrsen U, Zeller W, Hossfeld DK. Chromosomal abnormality irv(3)(q21q26) associated with mutilineage hematopoietic progenitor cells in hematopoietic malignancies. Cancer Genet Cytogenet 1997; 96:58-63.
9. Bernstein R, Pinto MR, Behr A, Mendelow B. Chromosome 3q abnormalities in acute non-lymphocytic leukemia (ANLL) with abnormal thrombopoiesis: report of three patients with a new inversion anomaly and a further case of homologous translocation. Blood 1982; 60:613-7.
10. Lee EJ, Schiffer CA, Tomiyasu T, Testa JR. Clinical and cytogenetic correlation of abnormal megakaryocytopoiesis in patients with acute leukemia and chronic myelogenous leukemia in blast crisis. Leukemia 1990; 4:350-3.
11. Bernstein R, Bagg A, Pinto M, Lewis D, Mendelow B. Chromosome 3q21 abnormalities associated with hyperactive thrombopoiesis in acute blastic transformation of chronic myeloid leukemia. Blood 1986; 68: 652-7.
12. Rowley JD, Potter D. Chromosomal banding patterns in acute nonlymphocytic leukemia. Blood 1976; 47: 705-21.
13. Mitelman F, Heim S. Quantative acute leukemia cytogenetics. Genes Chromosome Cancer 1992; 5:57-66.
14. Testoni N, Lemoli RM, Martinelli G, et al. Autologous bone marrow transplantation in acute myeloblastic leukemia and myelodysplastic syndrome patients: evaluation of tumour cell contamination of leukaphereses by cytogenetic and molecular methods. Bone Marrow Transplant 1998; 22:1065-70.
15. ISCN 1995. An International System for Human Cytogenetic Nomenclature. Mitelman F, ed. S. Karger: Basel, 1995.
16. Martinelli G, Testoni N, Montefusco V, et al. Detection of bcr-abl transcript in chronic myelogenous leukemia patients by reverse transcription-polymerase chain reaction and capillary electrophoresis. Haematologica 1998; 83:593-601.
17. Russell M, List A, Greenberg P, et al. Expression of EVI-1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocation. Blood 1994; 84:1243-8.
18. Martinelli G, Ottaviani E, Visani G, Testoni N, Montefusco V, Tura S. Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular level. Haematologica 1998; 83:860-3.
19. Testoni N, Martinelli G, Farabegoli P, et al. A new method of "In-cell reverse transcriptase-polymerase chain reaction" for the detection of BCR/ABL transcript in chronic myeloid leukemia after autologous bone marrow transplantation. Blood 1996; 18:1141-5.
20. Fourth International Workshop on Chromosomes in Leukemia 1982. Cancer Genet Cytogenet 1984; 11: 249-360.
21. Kuong YL, Wong KF. Translocation (8;21)(q22;q22) and the myelodysplastic syndrome. Leuk Res 1995; 19: 675-7.
22. Horsman DE, Gascoyne RD, Barnett MJ. Acute leukemia with structural rearrangements of chromosome 3. Leuk Lymphoma 1995; 16:369-77.
23. La Starza R, Falzetti D, Fania C, Tabilio A, Martelli MM, Mecucci C. 3q aberration and monosomy 7 in ANLL presenting with high platelet count and diabetes insipidus. Haematologica 1994; 79:356-9.
24. Pedersen-Bjergaard J, Pedersen M, Roulston D, Philip P. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood 1995; 86:3542-52.
25. Bouscary D, Fountenay-Roupie M, Chretien S, et al. Thrombopoietin is not responsible for the thrombocytosis observed in patients with acute myeloid leukemias and the 3q21q26 syndrome. Br J Haematol 1995; 91:425-7.
26. Schnittger S, de Savage FJ, Le Paslier D, Fonatsch C. Refined chromosomal localization of the human thrombopoietin gene to 3q27-q28 and exclusion as the responsible gene for thrombocytosis in patients with rearrangements of 3q21 and 3q26. Leukemia 1996; 10:1891-6.
27. Morishita K, Parganas E, Douglass EC, Ihle JN. Unique expression of the human EVI-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts. Oncogene 1990; 5:963.
28. Fichelson S, Dreygus F, Berger R, et al. EVI-1 expression in leukemic patients with rearrangements of 3q25-q28 chromosomal region. Leukemia 1992; 6:93-9.
29. Morishita K, Parganas E, Willman CL, et al. Activation of EVI-1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilo-bases on chromosome band 3q26. Proc Natl Acad Sci USA 1992; 89:3937-41.
30. Suzukawa K, Parganas E, Gajjar A, et al. Identification of a breakpoint cluster region 3' of the myelogenous ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute leukemia with inv(3)(q21q26). Blood 1994; 84:2681-8.
31. Levy ER, Parganas E, Morishita K, et al. DNA rearrangements proximal to the EVI-1 locus associated with the 3q21q26 syndrome. Blood 1994; 83:1348-54.
32. Nucifora G. The EVI-1 gene in myeloid leukemia. Leukemia 1997; 11:2022-31.
33. Hamaguchi H, Suzukawa K, Nagata K, Yamamoto K, Yagasaki F, Morishita K. Establishment of a novel human myeloid leukaemia cell line (HNT-34) with t(3;3)(q21q26),t(9;22)(q34;q11) and the expression of EVI-1 gene, P210 and P190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome. Br J Haematol 1997; 98:399-407.